Compare AEXA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEXA | MGTX |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.5M | 579.5M |
| IPO Year | 2025 | N/A |
| Metric | AEXA | MGTX |
|---|---|---|
| Price | $11.24 | $7.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.83 |
| AVG Volume (30 Days) | 262.9K | ★ 406.6K |
| Earning Date | 01-01-0001 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,417,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $569.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 96.83 |
| 52 Week Low | $10.49 | $4.55 |
| 52 Week High | $11.91 | $9.73 |
| Indicator | AEXA | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 38.61 | 44.55 |
| Support Level | $11.25 | $7.22 |
| Resistance Level | $11.80 | $7.70 |
| Average True Range (ATR) | 0.25 | 0.39 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 2.63 | 23.01 |
American Exceptionalism Acquisition Corp A is a blank check company.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.